Patent Filing

Curative Biotechnology secures a key U.S. patent for a metformin eye-drop, a novel approach that could transform treatment for macular degeneration.

A mining firm just secured a key gene therapy patent for ALS. Timothy Bell dissects the audacious strategy of funding cutting-edge biotech with Greenland's mineral wealth.

Amplia Therapeutics' new patent application for novel FAK inhibitors extends protection to 2046, signaling a major play in oncology and fibrosis markets.

A software firm just patented the future of your car: a system for privacy, payments, and data. We explore how this will change driving and car ownership.

A new patent for a tiny motor isn't just a technical win; it's a blueprint for more durable, compact, and maintainable robots, from humanoid hands to factory lines.

Vyome Holdings secures a key patent in China, not by betting the farm, but by making a shrewd, capital-efficient move to tap into a massive future market.

A Singapore-based company has patented a device to end large incisions in colorectal surgery, promising fewer infections and faster patient recovery.

A breakthrough at a Turkish mine sees ACG Metals achieve 85% gold recovery while slashing toxic cyanide use by 45%. Is this the future of greener, more profitable mining?

With a new U.S. patent, Quoin Pharmaceuticals reinforces its strategy for QRX003, a potential first-ever treatment for devastating Netherton Syndrome.

Allarity Therapeutics just secured a patent until 2042 for its cancer diagnostic. Is this the key to unlocking personalized treatment or a risky biotech bet?

The milestone isn't just a number; it's a blueprint for competitive advantage. A deep dive into how decades of innovation now position NETSCOUT at the heart of AI-driven security and 5G assurance.

Equifax secured 39 patents this year, doubling down on explainable AI. Is this the key to transparent credit scoring and a safer digital economy?

A small South Carolina firm just patented a screw-based system that ditches concrete. It’s not just about easier fences; it’s a lesson in market disruption.

A new patent for a non-hallucinogenic compound positions Clearmind Medicine to disrupt the multi-billion dollar market for addiction and compulsive disorders.

A new patent in South Korea for a novel breast cancer vaccine offers a potential paradigm shift from treatment to prevention, but the road from patent to patient is long.

A breakthrough oral vaccine from Singaporean scientists promises to end a devastating fish virus, bolstering food security and transforming aquaculture economics.

As pharma giants battle with blockbuster drugs, one company is betting on a simple, non-systemic hydrogel. Is this the future of weight management?

Valence AI just raised $5M and secured patents for tech that hears how you feel. It promises better service, but can a machine truly understand us?

With a new patent for its AI-powered VVC device, Zero Candida is betting on smart technology to solve a persistent health issue where drugs often fail.